ARCHIVES

In Brief: NCAB Objects To Low Priority For Several Cancer Control Grants, Asks For New Review

This article is from The Cancer Letter archive.

Vol. 05 No. 25 | June 22, 1979

Download PDF Visit The Full Archive

Related Articles

NCI-Approved Clinical Trials

December 29, 2006

Phase II Study Finds Dasatinib May Overcome ALL Resistance

May 25, 2007

In Brief: Lombardi Comprehensive Designation Renewed; Yale Plans Breast Cancer Lab

September 26, 1997

In Brief: FDA commissioner Kessler To Resign, Says His Goals Were Accomplished

November 29, 1996

Turmoil in Texas: DePinho Recommended AVEO Stock on CNBC Six Days After FDA Said New Trial Was Needed

May 10, 2013

NCI Starts “Exceptional Responders” Study

September 26, 2014